Lipocalin‐2 activates hepatic stellate cells and promotes nonalcoholic steatohepatitis in high‐fat diet–fed Ob/Ob mice
Authors:
Open Access
- 17 February 2023
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 77 (3) , 888-901
Abstract
Background and Aims: In obesity and type 2 diabetes mellitus, leptin promotes insulin resistance and contributes to the progression of NASH via activation of hepatic stellate cells (HSCs). However, the pathogenic mechanisms that trigger HSC activation in leptin‐deficient obesity are still unknown. This study aimed to determine how HSC‐targeting lipocalin‐2 (LCN2) mediates the transition from simple steatosis to NASH. Approach and Results: Male wild‐type (WT) and ob/ob mice were fed a high‐fat diet (HFD) for 20 weeks to establish an animal model of NASH with fibrosis. Ob/ob mice were subject to caloric restriction or recombinant leptin treatment. Double knockout (DKO) mice lacking both leptin and lcn2 were also fed an HFD for 20 weeks. In addition, HFD‐fed ob/ob mice were treated with gadolinium trichloride to deplete Kupffer cells. The LX‐2 human HSCs and primary HSCs from ob/ob mice were used to investigate the effects of LCN2 on HSC activation. Serum and hepatic LCN2 expression levels were prominently increased in HFD‐fed ob/ob mice compared with normal diet‐fed ob/ob mice or HFD‐fed WT mice, and these changes were closely linked to liver fibrosis and increased hepatic α‐SMA/matrix metalloproteinase 9 (MMP9)/signal transducer and activator of transcription 3 (STAT3) protein levels. HFD‐fed DKO mice showed a marked reduction of α‐SMA protein compared with HFD‐fed ob/ob mice. In particular, the colocalization of LCN2 and α‐SMA was increased in HSCs from HFD‐fed ob/ob mice. In primary HSCs from ob/ob mice, exogenous LCN2 treatment induced HSC activation and MMP9 secretion. By contrast, LCN2 receptor 24p3R deficiency or a STAT3 inhibitor reduced the activation and migration of primary HSCs. Conclusions: LCN2 acts as a key mediator of HSC activation in leptin‐deficient obesity via α‐SMA/MMP9/STAT3 signaling, thereby exacerbating NASH.Keywords
Funding Information
- National Research Foundation of Korea (2015R1A5A2008833, 2018R1A6A3A01012427, 2021R1A2C2093913)
This publication has 52 references indexed in Scilit:
- Hyperresponsivity to Low-Dose Endotoxin during Progression to Nonalcoholic Steatohepatitis Is Regulated by Leptin-Mediated SignalingCell Metabolism, 2012
- Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitisWorld Journal of Gastroenterology, 2012
- Critical role of tumor necrosis factor receptor 1, but not 2, in hepatic stellate cell proliferation, extracellular matrix remodeling, and liver fibrogenesisHepatology, 2011
- Downregulation of hepatic stellate cell activation by retinol and palmitate mediated by adipose differentiation‐related protein (ADRP)Journal of Cellular Physiology, 2010
- Hepatic stellate cell lipid droplets: A specialized lipid droplet for retinoid storageBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2009
- Mechanisms of Hepatic FibrogenesisGastroenterology, 2008
- Lack of inducible nitric oxide synthase leads to increased hepatic apoptosis and decreased fibrosis in mice after chronic carbon tetrachloride administrationHepatology, 2008
- Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesisProceedings of the National Academy of Sciences, 2007
- A Matrix Metalloproteinase-9 Activation Cascade by Hepatic Stellate Cells in Trans-differentiation in the Three-dimensional Extracellular MatrixJournal of Biological Chemistry, 2007
- Up-regulation of ADRP in fatty liver in human and liver steatosis in mice fed with high fat dietBiochemical and Biophysical Research Communications, 2006